1. Home
  2. PRDO vs NVAX Comparison

PRDO vs NVAX Comparison

Compare PRDO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

N/A

Current Price

$29.08

Market Cap

2.0B

Sector

Real Estate

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$8.52

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRDO
NVAX
Founded
1994
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
PRDO
NVAX
Price
$29.08
$8.52
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $14.11
AVG Volume (30 Days)
621.8K
★ 6.1M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 2.33%
N/A
EPS Growth
10.50
★ 309.76
EPS
★ 2.31
N/A
Revenue
$581,296,000.00
★ $1,123,479,000.00
Revenue This Year
$1.53
N/A
Revenue Next Year
$1.86
N/A
P/E Ratio
$12.56
★ N/A
Revenue Growth
N/A
★ 64.69
52 Week Low
$26.24
$6.20
52 Week High
$38.50
$13.39

Technical Indicators

Market Signals
Indicator
PRDO
NVAX
Relative Strength Index (RSI) 40.37 37.52
Support Level $26.24 $7.81
Resistance Level $34.94 $10.53
Average True Range (ATR) 1.34 0.76
MACD -0.11 -0.16
Stochastic Oscillator 41.65 5.98

Price Performance

Historical Comparison
PRDO
NVAX

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: